Scott Glenn

Scott Glenn General Information

Biography

Mr. Scott Glenn is the Founder at Windamere Venture Partners and also serves as its Managing Partner. He serves as Board Member at Mirador Therapeutics. He is a Co-Founder and serves as Chairman at Ourself. He is a Co-Founder & serves as Chairman at Rebalance. He also served as Chairman at Oncternal Therapeutics. He is also a Co-Founder & serves as a Board Member at Evoke Pharma. He is the past founder of Prometheus Laboratories, Inc., Santarus, Inc., DexCom Inc., Cadence Pharmaceuticals, NovaCardia Inc., Somaxon Pharmaceuticals, Zogenix, SpineWave, SkinMedica, Inc. and Conception Technologies, Inc., and currently serves on the board of directors of Tokalas, Inc. He founded and served as the Chief Executive Officer and Chairman at Alastin Skincare. Prior to his involvement in venture capital, he was the President and Chief Executive Officer of Quidel Corporation. Prior to Quidel, he held various management positions, including Division General Manager with Allergan, Inc. He holds a B.S. in Finance and Accounting from California State University at Fullerton. As one of the co-founders and has served on the board since June 2007, His extensive knowledge of the business and history, experience as a board member of multiple publicly-traded and privately-held companies, and expertise in developing, financing, and providing strong executive leadership to numerous biopharmaceutical companies contributed to the board of directors' conclusion that he should serve as a director of the company. He served as a Board Member at Kalyra Pharmaceuticals